CareLit Fachartikel

CheckMate 817: Safety of flat-dose nivolumab (nivo) plus weight-based ipilimumab (ipi) for the first lie (1 L) treatment of advanced non-small cell lung cancer (NSCLC)

JR Fischer, L Paz-Ares, L Urban, C Audigier-Valette, F Grossi, K Jao, JS Aucoin, H Linardou, E Vladimirovna Poddubskaya, A Cuiioni Fontecedro, HJM Groen, K Vermaelen, M Bourhaba, D Kowalski, R Narayana Pillai, DR Spigel, S Ahmed, W Hu, D Vickery, J Fiore, N R… · Pneumologie · 2019 · Heft S 01 S 01

Dokument
1194936
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
JR Fischer, L Paz-Ares, L Urban, C Audigier-Valette, F Grossi, K Jao, JS Aucoin, H Linardou, E Vladimirovna Poddubskaya, A Cuiioni Fontecedro, HJM Groen, K Vermaelen, M Bourhaba, D Kowalski, R Narayana Pillai, DR Spigel, S Ahmed, W Hu, D Vickery, J Fiore, N R…
Ausgabe
Heft S 01 S 01 / 2019
Jahrgang 73
Seiten
–
Erschienen: 2019-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-1678251

Zusammenfassung

CheckMate 817: Safety of flat-dose nivolumab (nivo) plus weight-based ipilimumab (ipi) for the first lie (1 L) treatment of advanced non-small cell lung cancer (NSCLC)

Schlagworte

Checkmate Safety Flat-Dose Nivolumab Weight-Based Ipilimumab First Treatment Advanced Non-Small Cancer Nsclc Pneumologie